265 related articles for article (PubMed ID: 26662991)
1. microRNA and NF-kappa B.
Yuan Y; Tong L; Wu S
Adv Exp Med Biol; 2015; 887():157-70. PubMed ID: 26662991
[TBL] [Abstract][Full Text] [Related]
2. Noncoding RNAs Regulating NF-κB Signaling.
Li M; Guan H
Adv Exp Med Biol; 2016; 927():317-36. PubMed ID: 27376741
[TBL] [Abstract][Full Text] [Related]
3. NF-κB target microRNAs and their target genes in TNFα-stimulated HeLa cells.
Zhou F; Wang W; Xing Y; Wang T; Xu X; Wang J
Biochim Biophys Acta; 2014; 1839(4):344-54. PubMed ID: 24418602
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers.
Tong L; Yuan Y; Wu S
Adv Drug Deliv Rev; 2015 Jan; 81():1-15. PubMed ID: 25220353
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA Roles in the Nuclear Factor Kappa B Signaling Pathway in Cancer.
Wu J; Ding J; Yang J; Guo X; Zheng Y
Front Immunol; 2018; 9():546. PubMed ID: 29616037
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.
Shukla K; Sharma AK; Ward A; Will R; Hielscher T; Balwierz A; Breunig C; Münstermann E; König R; Keklikoglou I; Wiemann S
Mol Oncol; 2015 Jun; 9(6):1106-19. PubMed ID: 25732226
[TBL] [Abstract][Full Text] [Related]
9. NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α.
Bao C; Li Y; Huan L; Zhang Y; Zhao F; Wang Q; Liang L; Ding J; Liu L; Chen T; Li J; Yao M; Huang S; He X
Sci Signal; 2015 Jul; 8(387):ra75. PubMed ID: 26221053
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-22 and microRNA-140 suppress NF-κB activity by regulating the expression of NF-κB coactivators.
Takata A; Otsuka M; Kojima K; Yoshikawa T; Kishikawa T; Yoshida H; Koike K
Biochem Biophys Res Commun; 2011 Aug; 411(4):826-31. PubMed ID: 21798241
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a.
Pacifico F; Crescenzi E; Mellone S; Iannetti A; Porrino N; Liguoro D; Moscato F; Grieco M; Formisano S; Leonardi A
J Clin Endocrinol Metab; 2010 Mar; 95(3):1421-30. PubMed ID: 20061417
[TBL] [Abstract][Full Text] [Related]
12. miR-21 and let-7 in the Ras and NF-κB pathways.
Choudhury SN; Li Y
Microrna; 2012; 1(1):65-9. PubMed ID: 25048092
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma.
Ding J; Huang S; Wang Y; Tian Q; Zha R; Shi H; Wang Q; Ge C; Chen T; Zhao Y; Liang L; Li J; He X
Hepatology; 2013 Aug; 58(2):654-66. PubMed ID: 23487264
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA analysis suggests an additional level of feedback regulation in the NF-κB signaling cascade.
Mechtler P; Singhal R; Kichina JV; Bard JE; Buck MJ; Kandel ES
Oncotarget; 2015 Jul; 6(19):17097-106. PubMed ID: 26020802
[TBL] [Abstract][Full Text] [Related]
15. Pax-5 Inhibits NF-κB Activity in Breast Cancer Cells Through IKKε and miRNA-155 Effectors.
Harquail J; LeBlanc N; Landry C; Crapoulet N; Robichaud GA
J Mammary Gland Biol Neoplasia; 2018 Sep; 23(3):177-187. PubMed ID: 30032344
[TBL] [Abstract][Full Text] [Related]
16. The interaction between miRNAs/lncRNAs and nuclear factor-κB (NF-κB) in human disorders.
Ghafouri-Fard S; Abak A; Fattahi F; Hussen BM; Bahroudi Z; Shoorei H; Taheri M
Biomed Pharmacother; 2021 Jun; 138():111519. PubMed ID: 33756159
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
[TBL] [Abstract][Full Text] [Related]
18. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.
Gao C; Zhang Z; Liu W; Xiao S; Gu W; Lu H
Cancer; 2010 Jan; 116(1):41-9. PubMed ID: 19890957
[TBL] [Abstract][Full Text] [Related]
19. Potential microRNA therapies targeting Ras, NFkappaB and p53 signaling.
Kasinski AL; Slack FJ
Curr Opin Mol Ther; 2010 Apr; 12(2):147-57. PubMed ID: 20373258
[TBL] [Abstract][Full Text] [Related]
20. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
Zhao L; Zhang Y
Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
